Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 07 - 19 tags : Research save search
New Labcorp Test Report Helps Identify Insect Stings and Improve Therapy Decisions to Combat Allergic Reactions
Published: 2022-07-19 (Crawled : 00:00) - biospace.com/
LH M | $208.19 2.52% 470K
|
Health Services
|
| O: 1.12%
H: 1.1%
C: 0.97%
report test therapy
SeaSpine Announces Three-Year Extension and Expansion of $30 Million Credit FacilityProvides for up to an additional $10 million of liquidity
Published: 2022-07-19 (Crawled : 00:00) - biospace.com/
SPNE | $9.54 8.29% -1.99%
|
Health Technology
|
| O: 5.21%
H: 0.0%
C: 0.0%
expansion extension seaspine
Belite Bio Submits Investigational New Drug (IND) Application to FDA for Approval to Proceed with LBS-008 Phase 3 Clinical Trial for the Treatment of Stargardt Disease
Published: 2022-07-19 (Crawled : 00:00) - biospace.com/
BLTE | $36.95 7.16% 20K
|
n/a
|
| O: -0.63%
H: 8.17%
C: 5.91%
lbs-008 treatment fda drug disease application trial approval
Contract Development and Manufacturing Organization Outsourcing Market size to grow by USD 64.44 billion, Market Research Insights highlights the growing pharmaceutical industry as Key Driver - Technavio
Published: 2022-07-19 (Crawled : 00:00) - prnewswire.com
TMO | News | $573.855 4.65% 1.7M
|
Health Technology
|
| O: 2.39%
H: 1.55%
C: -0.25%
research growing contract market
Myriad Genetics to Share Update on Business Transformation, Research and Development Pipeline, and Growth Plans at Investor Day on Aug. 11, 2022
Published: 2022-07-19 (Crawled : 22:00) - globenewswire.com
MYGN | $18.89 2.16% 240K
|
Health Technology
|
| O: 0.97%
H: 10.36%
C: 10.19%
day research update growth
Propanc Biopharma Successfully Produces Synthetic Recombinant Trypsinogen Via POP1 Joint Research & Drug Discovery Program
Published: 2022-07-19 (Crawled : 16:00) - biospace.com/
PPCB | $0.0011 -41.86% 5.6M
|
Manufacturing
|
| O: 0.0%
H: 8.0%
C: -8.0%
biopharma drug research program
Izotropic Engages Clinical Research Organization in Preparation for Clinical Study
Published: 2022-07-19 (Crawled : 15:00) - biospace.com/
ICLR | News | $306.815 2.98% 480K
|
Health Technology
|
| O: 1.89%
H: 2.86%
C: 2.52%
research study
Slope Appoints Clinical Research Veteran Hope Meely as Slope Chief Clinical Officer
Published: 2022-07-19 (Crawled : 15:00) - prnewswire.com
SNY | News | $47.72 1.21% 1.1M
|
Health Technology
|
| O: 2.11%
H: 0.0%
C: 0.0%
research
Wi-Fi 6 Market size worth $ 32.6 Billion, Globally, by 2030 at 13.06% CAGR: Verified Market Research®
Published: 2022-07-19 (Crawled : 14:00) - prnewswire.com
INTC | $34.43 0.06% 22M
|
Electronic Technology
|
| O: 0.56%
H: 3.59%
C: 2.29%
research market
Malt Whisky Market to Reach $6.7 Bn, Globally, by 2031 at 4.7% CAGR: Allied Market Research
Published: 2022-07-19 (Crawled : 13:20) - prnewswire.com
DGEAF | News | $35.0 1.5K
|
Consumer Non-Durables
|
| O: -5.38%
H: 0.0%
C: 0.0%
DEO | News | $140.85 -0.89% 440K
|
Consumer Non-Durables
|
| O: 1.66%
H: 1.09%
C: 1.05%
research market
Endpoint Detection and Response Market to Garner $18.3 Bn, Globally, by 2031 at 25.3% CAGR: Allied Market Research
Published: 2022-07-19 (Crawled : 13:00) - prnewswire.com
PANW | $293.41 4.16% 2.8M
|
Electronic Technology
|
| O: 0.56%
H: 1.36%
C: 0.97%
MSFT | News F | $407.2 1.56% 8.5M
|
Technology Services
|
| O: -0.8%
H: 0.83%
C: 0.76%
INTC | $34.43 0.06% 22M
|
Electronic Technology
|
| O: 0.56%
H: 3.59%
C: 2.29%
CSCO | News | $48.29 0.31% 6.9M
|
Technology Services
|
| O: 0.52%
H: 2.97%
C: 2.83%
research response market
Apellis Announces FDA Acceptance and Priority Review of the New Drug Application for Pegcetacoplan for the Treatment of Geographic Atrophy (GA)
Published: 2022-07-19 (Crawled : 13:00) - biospace.com/
APLS G | $48.32 1.43% 560K
|
Health Technology
|
| O: 26.05%
H: 0.89%
C: -7.73%
treatment fda drug application review
Nascent Biotech Receives Notice of Allowance from USPTO for Issuance of Additional Patent
Published: 2022-07-19 (Crawled : 13:00) - biospace.com/
NBIO | $0.0898 190K
|
|
| O: 0.0%
H: 3.7%
C: -2.26%
patent biotech
Establishment Labs Releases 2021 Sustainability Review
Published: 2022-07-19 (Crawled : 13:00) - biospace.com/
ESTA | $49.37 2.28% 160K
|
Health Technology
|
| O: 1.86%
H: 1.06%
C: -0.11%
review
Emergent Executes Letter of Intent To Acquire Evolutionary Biologics; Former L'Oréal President Jim Morrison To Become Full Time CEO of Emergent
Published: 2022-07-19 (Crawled : 13:00) - biospace.com/
EMGE | $0.0024 94.44% 470K
|
Wholesale Trade
|
| O: 14.29%
H: 23.33%
C: -22.5%
ceo acquire
PharmaCyte Biotech Reports Positive Interim Results in Malignant Ascites Mouse Model Study
Published: 2022-07-19 (Crawled : 13:00) - biospace.com/
PMCB | $2.22 1.3K
|
Manufacturing
|
| O: 0.42%
H: 2.11%
C: 0.84%
biotech positive results study
Novavax Announces Expanded Agreement with SK bioscience to Manufacture COVID-19 Vaccine Containing Omicron Variant and Manufacture the Novavax COVID-19 Vaccine in Prefilled Syringes
Published: 2022-07-19 (Crawled : 13:00) - biospace.com/
NVAX | $4.245 4.3% 2.3M
|
Health Technology
|
| O: 1.44%
H: 13.25%
C: 10.02%
covid-19 vaccine agreement bioscience
Antengene Announces Research Collaboration with Celularity to Evaluate the Potential Therapeutic Synergy of Combining Antengene's Best-in-Class Bispecific Antibody with Celularity's Natural Killer Cell Platform
Published: 2022-07-19 (Crawled : 12:20) - biospace.com/
CELU | News F | $3.3 7.84% 16K
|
|
| O: 1.39%
H: 0.55%
C: -4.37%
research collaboration antibody potential platform
Viking Therapeutics Announces FDA Has Lifted Clinical Hold on Phase 1b Trial of VK0214 in Patients with X-ALD
Published: 2022-07-19 (Crawled : 12:00) - biospace.com/
VKTX | $65.29 2.26% 1.6M
|
Health Technology
|
| O: -0.86%
H: 4.78%
C: 2.03%
LGND | $70.83 3.36% 77K
|
Health Technology
|
| O: 1.9%
H: 2.23%
C: 0.6%
vk0214 fda lifted trial therapeutics phase 2b clinical hold
IDEXX Announces New Goals in Its 2021 Corporate Responsibility Report and Advances Progress on Environmental, Social, and Governance Initiatives
Published: 2022-07-19 (Crawled : 12:00) - biospace.com/
IDXX | $493.555 2.92% 220K
|
Health Technology
|
| O: 2.44%
H: 2.79%
C: 2.08%
report
Gainers vs Losers
| 86% | 14% |
Top 10 Gainers
MTTR | News M | $4.56 162.07% 21M
|
AGBA | $2.74 119.2% 52M
|
Finance
CZOO | $9.07 81.76% 22M
|
EDBL | News | $6.56 74.47% 1.8M
|
MTC | $2.21 41.67% 5.6M
|
Technology Services
OPRT | News | $3.12 38.67% 11M
|
Finance
PALI | $6.59 33.67% 23M
|
Manufacturing
VNRX | $0.7989 33.15% 3.2M
|
Health Technology
BTCM | $3.51 30.0% 730K
|
Arts, Entertainment, and Recrea...
MLEC | $1.81 29.29% 2.8M
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.